November 01, 2015 - MM&M - Medical Marketing and Media

Print Issue: November 01, 2015

Upward Move: Lee Davies

Upward move.pdf After a 40-year career in communications, Lee Davies—the recently appointed SVP, director of client services for Makovsky’s health practice—says his next big goal is to “prepare the next generation of great communicatiors for the challenges and opportunities they will face. “My role is to share everything I have gleaned from all my experiences…

At Work With . . . Amber Rogers

At Work With Amber Rogers.pdf Q: What was your biggest break?  One of my college professors invited me to join a medical communications company as an intern while I was still in school. It was a small company but that meant that I was immediately able to roll up my sleeves and dig into a…

Private View: Stephanie Berman

Private View.pdf It can be hard to keep an edge in healthcare. We’re oh so sensi­tive about upsetting and offend­ing and being squeam­ish about health. Playing it safe is so much easier. But it’s way less fun. I would also argue that it’s way less likely to make a difference, whether you’re looking to drive disease…

A Gateway Drug to Less Pain and Suffering

Viewpoint.pdf Did you happen to catch the one question that got passed from speak er to speaker like a lit joint during the first Democratic presidential debate? “If elected president, would you legalize medical marijuana?” Talk about peer pressure. Every candidate, even those who claim never to have smoked pot, drew a deep breath before…

Not a Pill Person? More a “Disease Person”?

Viewpoint.pdfWhen patients with high blood pressure say, “I’m not a pill person,” are they really saying, “I’m more of a disease person”? Of course not. It’s not so much that they’re okay with the chronic condition or potentially suffering its downstream complications. It’s more that they fear the risks of the medication more than the…

Therapeutic Focus: Neurology

The neurology space is gearing up to shake free of its decade-long stagnancy, with sector leaders and runners-up alike angling to push the boundaries. What that means: Imminent advances in genetic sequencing, targeted treatments and diagnostics, all designed to get to the biological root of neurological disorders. Rebecca Mayer Knutsen explains